Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9973 to 9984 of 196347 entries
Sorted by: Best Match Show Resources per page
Automatic Assembly of Ultra-Multilayered Nanotube-Nanoparticle Composites.

Chemistry, an Asian journal

Fan R, Li J, Fei J, Zhao J, Wang A, Sun B, Li J.
PMID: 27166977
Chem Asian J. 2016 Oct 06;11(19):2667-2670. doi: 10.1002/asia.201600405. Epub 2016 Jun 15.

Nanotube-nanoparticle composites are fabricated by template-directed automatic layer-by-layer assembly with the assistance of pressure. This assembly strategy above allows the facile construction of uniform complex nanostructures with ultra-multilayers (≈200). Importantly, it takes much less time than conventional manual manipulation.

Cite
Fan R, Li J, Fei J, et al. Automatic Assembly of Ultra-Multilayered Nanotube-Nanoparticle Composites. Chem Asian J. 2016;11(19):2667-2670doi: 10.1002/asia.201600405.
Fan, R., Li, J., Fei, J., Zhao, J., Wang, A., Sun, B., & Li, J. (2016). Automatic Assembly of Ultra-Multilayered Nanotube-Nanoparticle Composites. Chemistry, an Asian journal, 11(19), 2667-2670. https://doi.org/10.1002/asia.201600405
Fan, Ruying, et al. "Automatic Assembly of Ultra-Multilayered Nanotube-Nanoparticle Composites." Chemistry, an Asian journal vol. 11,19 (2016): 2667-2670. doi: https://doi.org/10.1002/asia.201600405
Fan R, Li J, Fei J, Zhao J, Wang A, Sun B, Li J. Automatic Assembly of Ultra-Multilayered Nanotube-Nanoparticle Composites. Chem Asian J. 2016 Oct 06;11(19):2667-2670. doi: 10.1002/asia.201600405. Epub 2016 Jun 15. PMID: 27166977.
Copy Download .nbib Format: NLM
Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts.

Oncotarget

Brana I, Pham NA, Kim L, Sakashita S, Li M, Ng C, Wang Y, Loparco P, Sierra R, Wang L, Clarke BA, Neel BG, Siu LL, Tsao MS.
PMID: 29156674
Oncotarget. 2017 Jul 08;8(49):84659-84670. doi: 10.18632/oncotarget.19109. eCollection 2017 Oct 17.

PTEN inactivation occurs commonly in human cancers and putatively activates the PI3K/AKT/ mTOR pathway. Activation of this pathway has been involved in resistance to chemotherapy or anti-EGFR/HER2 therapies. We evaluated the combination of PI3K-mTOR inhibitors with chemotherapy or the...

Cite
Brana I, Pham NA, Kim L, et al. Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts. Oncotarget. 2017;8(49):84659-84670doi: 10.18632/oncotarget.19109.
Brana, I., Pham, N. A., Kim, L., Sakashita, S., Li, M., Ng, C., Wang, Y., Loparco, P., Sierra, R., Wang, L., Clarke, B. A., Neel, B. G., Siu, L. L., & Tsao, M. S. (2017). Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts. Oncotarget, 8(49), 84659-84670. https://doi.org/10.18632/oncotarget.19109
Brana, Irene, et al. "Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts." Oncotarget vol. 8,49 (2017): 84659-84670. doi: https://doi.org/10.18632/oncotarget.19109
Brana I, Pham NA, Kim L, Sakashita S, Li M, Ng C, Wang Y, Loparco P, Sierra R, Wang L, Clarke BA, Neel BG, Siu LL, Tsao MS. Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts. Oncotarget. 2017 Jul 08;8(49):84659-84670. doi: 10.18632/oncotarget.19109. eCollection 2017 Oct 17. PMID: 29156674; PMCID: PMC5689564.
Copy Download .nbib Format: NLM
Multiple quasicrystal approximants with the same lattice parameters in Al-Cr-Fe-Si alloys.

Scientific reports

He Z, Li H, Ma H, Li G.
PMID: 28084405
Sci Rep. 2017 Jan 13;7:40510. doi: 10.1038/srep40510.

By means of atomic-resolution high-angle annular dark-field scanning transmission electron microscopy, we found three types of giant approximants of decagonal quasicrystal in Al-Cr-Fe-Si alloys, where each type contains several structural variants possessing the same lattice parameters but different crystal...

Cite
He Z, Li H, Ma H, et al. Multiple quasicrystal approximants with the same lattice parameters in Al-Cr-Fe-Si alloys. Sci Rep. 2017;7:40510doi: 10.1038/srep40510.
He, Z., Li, H., Ma, H., & Li, G. (2017). Multiple quasicrystal approximants with the same lattice parameters in Al-Cr-Fe-Si alloys. Scientific reports, 740510. https://doi.org/10.1038/srep40510
He, Zhanbing, et al. "Multiple quasicrystal approximants with the same lattice parameters in Al-Cr-Fe-Si alloys." Scientific reports vol. 7 (2017): 40510. doi: https://doi.org/10.1038/srep40510
He Z, Li H, Ma H, Li G. Multiple quasicrystal approximants with the same lattice parameters in Al-Cr-Fe-Si alloys. Sci Rep. 2017 Jan 13;7:40510. doi: 10.1038/srep40510. PMID: 28084405; PMCID: PMC5233979.
Copy Download .nbib Format: NLM
Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cells.

Oncotarget

Fang J, Ying H, Mao T, Fang Y, Lu Y, Wang H, Zang I, Wang Z, Lin Y, Zhao M, Luo X, Wang Z, Zhang Y, Zhang C, Xiao W, Wang Y, Tan W, Chen Z, Lu C, Atadja P, Li E, Zhao K, Liu J, Gu J.
PMID: 29156705
Oncotarget. 2017 Jun 19;8(49):85085-85101. doi: 10.18632/oncotarget.18564. eCollection 2017 Oct 17.

LSD1 (Lysine Specific Demethylase1)/KDM1A (Lysine Demethylase 1A), a flavin adenine dinucleotide (FAD)-dependent histone H3K4/K9 demethylase, sustains oncogenic potential of leukemia stem cells in primary human leukemia cells. However, the pro-differentiation and anti-proliferation effects of LSD1 inhibition in acute myeloid...

Cite
Fang J, Ying H, Mao T, et al. Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cells. Oncotarget. 2017;8(49):85085-85101doi: 10.18632/oncotarget.18564.
Fang, J., Ying, H., Mao, T., Fang, Y., Lu, Y., Wang, H., Zang, I., Wang, Z., Lin, Y., Zhao, M., Luo, X., Wang, Z., Zhang, Y., Zhang, C., Xiao, W., Wang, Y., Tan, W., Chen, Z., Lu, C., Atadja, P., Li, E., Zhao, K., Liu, J., & Gu, J. (2017). Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cells. Oncotarget, 8(49), 85085-85101. https://doi.org/10.18632/oncotarget.18564
Fang, Jianwu, et al. "Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cells." Oncotarget vol. 8,49 (2017): 85085-85101. doi: https://doi.org/10.18632/oncotarget.18564
Fang J, Ying H, Mao T, Fang Y, Lu Y, Wang H, Zang I, Wang Z, Lin Y, Zhao M, Luo X, Wang Z, Zhang Y, Zhang C, Xiao W, Wang Y, Tan W, Chen Z, Lu C, Atadja P, Li E, Zhao K, Liu J, Gu J. Upregulation of CD11b and CD86 through LSD1 inhibition promotes myeloid differentiation and suppresses cell proliferation in human monocytic leukemia cells. Oncotarget. 2017 Jun 19;8(49):85085-85101. doi: 10.18632/oncotarget.18564. eCollection 2017 Oct 17. PMID: 29156705; PMCID: PMC5689595.
Copy Download .nbib Format: NLM
Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model.

Oncotarget

Kawaguchi K, Igarashi K, Li S, Han Q, Tan Y, Kiyuna T, Miyake K, Murakami T, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Unno M, Eilber FC, Hoffman RM.
PMID: 29156737
Oncotarget. 2017 Aug 12;8(49):85516-85525. doi: 10.18632/oncotarget.20231. eCollection 2017 Oct 17.

An excessive requirement for methionine termed methionine dependence, appears to be a general metabolic defect in cancer. We have previously shown that cancer-cell growth can be selectively arrested by methionine deprivation such as with recombinant methioninase (rMETase). The present...

Cite
Kawaguchi K, Igarashi K, Li S, et al. Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model. Oncotarget. 2017;8(49):85516-85525doi: 10.18632/oncotarget.20231.
Kawaguchi, K., Igarashi, K., Li, S., Han, Q., Tan, Y., Kiyuna, T., Miyake, K., Murakami, T., Chmielowski, B., Nelson, S. D., Russell, T. A., Dry, S. M., Li, Y., Unno, M., Eilber, F. C., & Hoffman, R. M. (2017). Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model. Oncotarget, 8(49), 85516-85525. https://doi.org/10.18632/oncotarget.20231
Kawaguchi, Kei, et al. "Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model." Oncotarget vol. 8,49 (2017): 85516-85525. doi: https://doi.org/10.18632/oncotarget.20231
Kawaguchi K, Igarashi K, Li S, Han Q, Tan Y, Kiyuna T, Miyake K, Murakami T, Chmielowski B, Nelson SD, Russell TA, Dry SM, Li Y, Unno M, Eilber FC, Hoffman RM. Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model. Oncotarget. 2017 Aug 12;8(49):85516-85525. doi: 10.18632/oncotarget.20231. eCollection 2017 Oct 17. PMID: 29156737; PMCID: PMC5689627.
Copy Download .nbib Format: NLM
Chromium doped Li.

Chemical communications (Cambridge, England)

Liu S, Wang J, Tian Z, Li Q, Tian X, Cui Y, Yang Y.
PMID: 29044253
Chem Commun (Camb). 2017 Oct 31;53(87):11913-11916. doi: 10.1039/c7cc07545f.

Cr-Doped Li

Cite
Liu S, Wang J, Tian Z, et al. Chromium doped Li. Chem Commun (Camb). 2017;53(87):11913-11916doi: 10.1039/c7cc07545f.
Liu, S., Wang, J., Tian, Z., Li, Q., Tian, X., Cui, Y., & Yang, Y. (2017). Chromium doped Li. Chemical communications (Cambridge, England), 53(87), 11913-11916. https://doi.org/10.1039/c7cc07545f
Liu, Shengzhou, et al. "Chromium doped Li." Chemical communications (Cambridge, England) vol. 53,87 (2017): 11913-11916. doi: https://doi.org/10.1039/c7cc07545f
Liu S, Wang J, Tian Z, Li Q, Tian X, Cui Y, Yang Y. Chromium doped Li. Chem Commun (Camb). 2017 Oct 31;53(87):11913-11916. doi: 10.1039/c7cc07545f. PMID: 29044253.
Copy Download .nbib Format: NLM
Prophylactic vertebroplasty procedure applied with a resorbable bone cement can decrease the fracture risk of sandwich vertebrae: long-term evaluation of clinical outcomes.

Regenerative biomaterials

Jia P, Tang H, Chen H, Bao L, Feng F, Yang H, Li J.
PMID: 28149529
Regen Biomater. 2017 Feb;4(1):47-53. doi: 10.1093/rb/rbw037. Epub 2016 Dec 30.

A sandwich vertebra is formed after multiple osteoporotic vertebral fractures treated by percutaneous vertebroplasty, which has a risk of developing new fractures. The purpose of our study was to (i) investigate the occurrence of new fractures in sandwich vertebra...

Cite
Jia P, Tang H, Chen H, et al. Prophylactic vertebroplasty procedure applied with a resorbable bone cement can decrease the fracture risk of sandwich vertebrae: long-term evaluation of clinical outcomes. Regen Biomater. 2016;4(1):47-53doi: 10.1093/rb/rbw037.
Jia, P., Tang, H., Chen, H., Bao, L., Feng, F., Yang, H., & Li, J. (2017). Prophylactic vertebroplasty procedure applied with a resorbable bone cement can decrease the fracture risk of sandwich vertebrae: long-term evaluation of clinical outcomes. Regenerative biomaterials, 4(1), 47-53. https://doi.org/10.1093/rb/rbw037
Jia, Pu, et al. "Prophylactic vertebroplasty procedure applied with a resorbable bone cement can decrease the fracture risk of sandwich vertebrae: long-term evaluation of clinical outcomes." Regenerative biomaterials vol. 4,1 (2017): 47-53. doi: https://doi.org/10.1093/rb/rbw037
Jia P, Tang H, Chen H, Bao L, Feng F, Yang H, Li J. Prophylactic vertebroplasty procedure applied with a resorbable bone cement can decrease the fracture risk of sandwich vertebrae: long-term evaluation of clinical outcomes. Regen Biomater. 2017 Feb;4(1):47-53. doi: 10.1093/rb/rbw037. Epub 2016 Dec 30. PMID: 28149529; PMCID: PMC5274705.
Copy Download .nbib Format: NLM
JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against .

Oncotarget

Wang H, Hong B, Li X, Deng K, Li H, Yan Lui VW, Lin W.
PMID: 29156797
Oncotarget. 2017 Sep 21;8(49):86312-86324. doi: 10.18632/oncotarget.21146. eCollection 2017 Oct 17.

Small cell lung cancer (SCLC) is a clinically aggressive cancer with very poor prognosis. Amplification of

Cite
Wang H, Hong B, Li X, et al. JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against . Oncotarget. 2017;8(49):86312-86324doi: 10.18632/oncotarget.21146.
Wang, H., Hong, B., Li, X., Deng, K., Li, H., Yan Lui, V. W., & Lin, W. (2017). JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against . Oncotarget, 8(49), 86312-86324. https://doi.org/10.18632/oncotarget.21146
Wang, Huogang, et al. "JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against ." Oncotarget vol. 8,49 (2017): 86312-86324. doi: https://doi.org/10.18632/oncotarget.21146
Wang H, Hong B, Li X, Deng K, Li H, Yan Lui VW, Lin W. JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against . Oncotarget. 2017 Sep 21;8(49):86312-86324. doi: 10.18632/oncotarget.21146. eCollection 2017 Oct 17. PMID: 29156797; PMCID: PMC5689687.
Copy Download .nbib Format: NLM
MicroRNAs are novel non-invasive diagnostic biomarkers for pulmonary embolism: a meta-analysis.

Journal of thoracic disease

Deng HY, Li G, Luo J, Wang ZQ, Yang XY, Lin YD, Liu LX.
PMID: 28149552
J Thorac Dis. 2016 Dec;8(12):3580-3587. doi: 10.21037/jtd.2016.12.98.

BACKGROUNDS: The diagnosis of pulmonary embolism (PE) still remains difficult in clinical practice. MicroRNAs (miRNAs) have been widely investigated as biomarkers for various diseases. However, the diagnostic biomarker value of miRNAs in the diagnosis of PE is unclear. Therefore,...

Cite
Deng HY, Li G, Luo J, et al. MicroRNAs are novel non-invasive diagnostic biomarkers for pulmonary embolism: a meta-analysis. J Thorac Dis. 2016;8(12):3580-3587doi: 10.21037/jtd.2016.12.98.
Deng, H. Y., Li, G., Luo, J., Wang, Z. Q., Yang, X. Y., Lin, Y. D., & Liu, L. X. (2016). MicroRNAs are novel non-invasive diagnostic biomarkers for pulmonary embolism: a meta-analysis. Journal of thoracic disease, 8(12), 3580-3587. https://doi.org/10.21037/jtd.2016.12.98
Deng, Han-Yu, et al. "MicroRNAs are novel non-invasive diagnostic biomarkers for pulmonary embolism: a meta-analysis." Journal of thoracic disease vol. 8,12 (2016): 3580-3587. doi: https://doi.org/10.21037/jtd.2016.12.98
Deng HY, Li G, Luo J, Wang ZQ, Yang XY, Lin YD, Liu LX. MicroRNAs are novel non-invasive diagnostic biomarkers for pulmonary embolism: a meta-analysis. J Thorac Dis. 2016 Dec;8(12):3580-3587. doi: 10.21037/jtd.2016.12.98. PMID: 28149552; PMCID: PMC5227248.
Copy Download .nbib Format: NLM
miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma.

Oncotarget

Wang X, Liu S, Cao L, Zhang T, Yue D, Wang L, Ping Y, He Q, Zhang C, Wang M, Chen X, Gao Q, Wang D, Zhang Z, Wang F, Yang L, Li J, Huang L, Zhang B, Zhang Y.
PMID: 29156819
Oncotarget. 2017 Sep 23;8(49):86592-86603. doi: 10.18632/oncotarget.21246. eCollection 2017 Oct 17.

Hepatocellular carcinoma (HCC), the most common primary tumor of the liver, has a poor prognosis and rapid progression. MicroRNAs (miRNAs) play important roles in carcinogenesis and tumor progression. Insulin-like growth factor 1 receptor (IGF1R) is a transmembrane heterotetrameric protein...

Cite
Wang X, Liu S, Cao L, et al. miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma. Oncotarget. 2017;8(49):86592-86603doi: 10.18632/oncotarget.21246.
Wang, X., Liu, S., Cao, L., Zhang, T., Yue, D., Wang, L., Ping, Y., He, Q., Zhang, C., Wang, M., Chen, X., Gao, Q., Wang, D., Zhang, Z., Wang, F., Yang, L., Li, J., Huang, L., Zhang, B., & Zhang, Y. (2017). miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma. Oncotarget, 8(49), 86592-86603. https://doi.org/10.18632/oncotarget.21246
Wang, Xiao, et al. "miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma." Oncotarget vol. 8,49 (2017): 86592-86603. doi: https://doi.org/10.18632/oncotarget.21246
Wang X, Liu S, Cao L, Zhang T, Yue D, Wang L, Ping Y, He Q, Zhang C, Wang M, Chen X, Gao Q, Wang D, Zhang Z, Wang F, Yang L, Li J, Huang L, Zhang B, Zhang Y. miR-29a-3p suppresses cell proliferation and migration by downregulating IGF1R in hepatocellular carcinoma. Oncotarget. 2017 Sep 23;8(49):86592-86603. doi: 10.18632/oncotarget.21246. eCollection 2017 Oct 17. PMID: 29156819; PMCID: PMC5689709.
Copy Download .nbib Format: NLM
Associations of high altitude polycythemia with polymorphisms in .

Oncotarget

Zhao Y, Zhang Z, Liu L, Zhang Y, Fan X, Ma L, Li J, Zhang Y, He H, Kang L.
PMID: 29156832
Oncotarget. 2017 Sep 30;8(49):86736-86746. doi: 10.18632/oncotarget.21420. eCollection 2017 Oct 17.

High altitude polycythemia (HAPC) is a common chronic disease at high altitude, which is characterized by excessive erythrocytosis (females, hemoglobin ≥ 190 g/L; males, hemoglobin ≥ 210 g/L). It is the most common disease in chronic mountain sickness casued...

Cite
Zhao Y, Zhang Z, Liu L, et al. Associations of high altitude polycythemia with polymorphisms in . Oncotarget. 2017;8(49):86736-86746doi: 10.18632/oncotarget.21420.
Zhao, Y., Zhang, Z., Liu, L., Zhang, Y., Fan, X., Ma, L., Li, J., Zhang, Y., He, H., & Kang, L. (2017). Associations of high altitude polycythemia with polymorphisms in . Oncotarget, 8(49), 86736-86746. https://doi.org/10.18632/oncotarget.21420
Zhao, Yiduo, et al. "Associations of high altitude polycythemia with polymorphisms in ." Oncotarget vol. 8,49 (2017): 86736-86746. doi: https://doi.org/10.18632/oncotarget.21420
Zhao Y, Zhang Z, Liu L, Zhang Y, Fan X, Ma L, Li J, Zhang Y, He H, Kang L. Associations of high altitude polycythemia with polymorphisms in . Oncotarget. 2017 Sep 30;8(49):86736-86746. doi: 10.18632/oncotarget.21420. eCollection 2017 Oct 17. PMID: 29156832; PMCID: PMC5689722.
Copy Download .nbib Format: NLM
3D SAPIV particle field reconstruction method based on adaptive threshold.

Applied optics

Qu X, Song Y, Jin Y, Li Z, Wang X, Guo Z, Ji Y, He A.
PMID: 29522010
Appl Opt. 2018 Mar 01;57(7):1622-1633. doi: 10.1364/AO.57.001622.

Particle image velocimetry (PIV) is a necessary flow field diagnostic technique that provides instantaneous velocimetry information non-intrusively. Three-dimensional (3D) PIV methods can supply the full understanding of a 3D structure, the complete stress tensor, and the vorticity vector in...

Cite
Qu X, Song Y, Jin Y, et al. 3D SAPIV particle field reconstruction method based on adaptive threshold. Appl Opt. 2018;57(7):1622-1633doi: 10.1364/AO.57.001622.
Qu, X., Song, Y., Jin, Y., Li, Z., Wang, X., Guo, Z., Ji, Y., & He, A. (2018). 3D SAPIV particle field reconstruction method based on adaptive threshold. Applied optics, 57(7), 1622-1633. https://doi.org/10.1364/AO.57.001622
Qu, Xiangju, et al. "3D SAPIV particle field reconstruction method based on adaptive threshold." Applied optics vol. 57,7 (2018): 1622-1633. doi: https://doi.org/10.1364/AO.57.001622
Qu X, Song Y, Jin Y, Li Z, Wang X, Guo Z, Ji Y, He A. 3D SAPIV particle field reconstruction method based on adaptive threshold. Appl Opt. 2018 Mar 01;57(7):1622-1633. doi: 10.1364/AO.57.001622. PMID: 29522010.
Copy Download .nbib Format: NLM
Showing 9973 to 9984 of 196347 entries